Activity ID
7925Expires
June 30, 2024Format Type
EnduringCME Credit
0.25Fee
$40CME Provider: Louisiana Medical Mutual Insurance Company (LAMMICO)
Description of CME Course
This is the twelfth of 17 modules in our hypertension in pregnancy series and focuses on the Institute of Safe Medication Practices (ISMP) recommendations for the safe administration of parenteral magnesium sulfate for seizure prophylaxis to reduce the risk of harm to pregnant and postpartum women and mitigate risk exposure.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Family Medicine
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Identify 3 clinical indications and contraindications to the use of magnesium sulfate in the prevention and treatment of seizures in pregnant and postpartum women. Adopt strategies to safely administer magnesium sulfate and reduce malpractice risk exposure.
Keywords
Hypertension in Pregnancy, OB Mortality, OB Safety
Competencies
Interpersonal & Communication Skills, Medical Knowledge, Practice-based Learning & Improvement, Professionalism
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Inpatient, Rural, Urban
